A machine learning lung cancer risk prediction model outperformed logistic regression, supporting improved risk assessment and more efficient radiology based lung cancer screening.

Noetik CEO and co-founder Ron Alfa, M.D., Ph.D., said the licensing of human foundation models is “a new paradigm in biotech.” With the GSK deal validating the paradigm, in Alfa’s view, Noetik ...

A new study presented at the International Association for the Study of Lung Cancer 2025 World Conference on Lung Cancer (WCLC) validates the use of Sybil, a deep learning artificial intelligence ...

Researchers have identified a previously unknown inflammatory mechanism that may drive the aggressiveness and relapse of ...

Informed and shared decision-making is essential in lung cancer treatment, emphasizing clinical trial participation for advancing therapies. CheckMate 816 study showed improved overall survival with ...

We currently know that COPD, and specifically emphysema, is not just a lung disease found alongside lung cancer; it increases ...